| Log in
Photo Credit: Satyakam Banerjee/VCCircle

True North makes partial exit from drug research firm with strong gains

18 May, 2017

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year. It sold a 4.5% stake in Mu ....

To read the Full Story

subscribe

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Exclusive: IVFA earns above-average return on partial exit from healthcare firm

Exclusive: IVFA earns above-average return on partial exit from healthcare firm

Joseph Rai 11 months ago
Private equity firm India Value Fund Advisors (IVFA), which raised a new fund...
Exclusive: Temasek bets on another Indian healthcare company

Exclusive: Temasek bets on another Indian healthcare company

Ranjani R 1 month ago
Singapore state investment firm Temasek Holdings has picked up a minority stake...
IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

Anuradha Verma 2 years ago
Syngene International Ltd, the research and development subsidiary of Indian...
No Comments

True North makes partial exit from drug research firm with strong gains

Powered by WordPress.com VIP